SELLAS Life Sciences (SLS) Change in Acquisitions & Divestments (2013)
SELLAS Life Sciences (SLS) reported Change in Acquisitions & Divestments of $2.5 million for Q4 2013, up 209.46% on a QoQ basis from $814000.0 in Q3 2013.
SELLAS Life Sciences (SLS) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $2.5 million in Q4 2013.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $2.5 million in Q4 2013, while the trailing twelve-month figure through Dec 2014 was $3.3 million (changed 0.0% YoY) and the FY2013 annual result came in at $3.9 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments improved to $2.5 million in Q4 2013 per SLS's latest filing, from $814000.0 in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $2.5 million in Q4 2013 and bottomed at $814000.0 in Q3 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 2.52 Mn |
| Dec 31, 2013 | 2.52 Mn |
| Sep 30, 2013 | 814,000.00 |
| Sep 30, 2013 | 814,000.00 |